LifeScience
Single Cell Discoveries Acquires TATAA Biocenter to Build Integrated Discovery-to-Validation CRO
Single Cell Discoveries (SCD), a specialist contract research organization (CRO) focused on discovery transcriptomics, has completed the acquisition of TAT...
September 16, 2026 | News
IonOpticks Launches Aurora Series 5 to Boost Robustness in High-Throughput Proteomics
New CoreJet™ integrated emitter technology and a redesigned nanoZero® union combine proven Aurora Series® performance with a step-change in r...
September 15, 2026 | News
HORIEN Secures Thai FDA Class 4 Approvals for Three Regenerative Medical Devices
Market-entry initiative targets qualified Thai distributors across dental, surgical, wound-care, and regenerative medicine channels, while solidifying glob...
September 09, 2026 | News
Evinova, Lothar Medical Partner to Digitise Respiratory Clinical Trials
Evinova, a global leader in AI-native clinical development technology, announced a strategic partnership with Lothar Medical to help transform the ex...
September 08, 2026 | News
Alteogen, Novartis Ink Up to $3.2B Deal for Subcutaneous Biologics Using ALT-B4
Novartis obtains rights to develop and commercialize subcutaneous formulations for multiple products utilizing ALT-B4 Alteogen's fourth licensing agreem...
September 04, 2026 | News
EpiVax Adds AI-Enabled Enhancements to ISPRI Immunogenicity Risk Platform
EpiVax, Inc. is pleased to announce the release of AI-enabled enhancements to ISPRI™, its proprietary in silico platform for assessing the ...
September 04, 2026 | News
IDT and Ansa Expand Global Access to Complex DNA Synthesis Through Integrated Ordering
Streamlined workflow provides earlier visibility into synthesis feasibility, pricing, and fulfillment options Global adoption growing with more than 400...
September 03, 2026 | News
Singapore Becomes First ASEAN Market to Subsidise Vutrisiran for ATTR Amyloidosis
"From September 2026 – eligible patients receiving vutrisiran will receive government subsidies of up to 75%[1],[2]" "HELIOS-A and B provide strong ...
September 02, 2026 | News
Thermo Fisher Strengthens China Focus as Biopharma Innovation Gains Global Momentum
Thermo Fisher Scientific is reinforcing its commitment to China as the country emerges as an increasingly important source of global biopharmaceutical inno...
September 01, 2026 | News
DualityBio, Genentech Ink $1B-Plus Deal to Develop Next-Generation ADCs Against Drug-Resistant Tumours
Collaboration leverages DualityBio's proprietary DUPAC payload platform and early global clinical development capabilities, with Genentech assuming furth...
August 31, 2026 | News
Monod Bio, SignalChem Biotech Ink Licensing Deal to Advance AI-Designed Protein Technologies
Monod Bio, a Seattle-based AI-enabled protein design company, and SignalChem Biotech Inc., a wholly-owned subsidiary of Sino Biological, Inc. announced a n...
August 28, 2026 | News
Biosidus Expands Biologics Manufacturing Capacity with New Bioreactor Plant in Argentina
Biosidus, an Argentine biotechnology company with more than four decades of experience in the development and manufacturing of biosimilar medicines, announ...
August 28, 2026 | News
GenScript CEO Sherry Shao Sees AI-Enabled Drug Discovery as Key Growth Engine After Strong H1 2026
Adjusted net profit surges 203.3% as Gene-to-Protein generates two-thirds of GenScript Life Science Group revenue GenScript Biotech Corporation (HKEX: 154...
August 20, 2026 | Company results
Henlius, Sandoz Expand Global Biosimilars Alliance with Up to 10 New Antibody Assets
Collaboration may cover up to 10 proposed monoclonal antibody (mAb) and/or antibody-drug conjugate (ADC) biosimilar assets, with the majority of programs...
August 18, 2026 | News
Most Read
- Can APAC Biomanufacturing Decarbonise Without Pricing Itself Out?
- The Algorithm on the GMP Floor: AI Promises a Smarter Plant. Regulators Demand the Audit Trail.
- APAC's Peptide-Capacity Gamble
- After the Rush: APAC's mRNA and Vaccine Capacity Hangover
- The Biosimilar Race: Factory to the World — or Stuck in the Copycat Economy?
- The Vein-to-Vein Problem: Can APAC's Cold Chain Carry Advanced Therapies?
- Vectors, Plasmids and the CGT Trap: APAC's Cell and Gene Therapy Ambitions Face an Upstream Bottleneck
- Can APAC Build Radioligand Therapy Before the Atoms Decay?
- The Great Biopharma Reset: 50 Developments That Changed Everything in H1 2026
- Beyond the Trial: Can Real-World Evidence Earn Regulatory Trust in APAC?
- Beyond the Obvious Giant: Where APAC's Clinical Trials Go Next
- The Frontier That Won’t Quite Arrive
Bio Jobs
- Sanofi Turns The Page As Belén Garijo Steps In And Paul Hudson Steps Out
- Global Survey Reveals Nearly 40% of Employees Facing Fertility Challenges Consider Leaving Their Jobs
- BioMed X and AbbVie Begin Global Search for Bold Neuroscience Talent To Decode the Biology of Anhedonia
- Thermo Fisher Expands Bengaluru R&D Centre to Advance Antibody Innovation and Strengthen India’s Life Sciences Ecosystem
- Accord Plasma (Intas Group) Acquires Prothya Biosolutions to Expand Global Plasma Capabilities
- ACG Announces $200 Million Investment to Establish First U.S. Capsule Manufacturing Facility in Atlanta
- AstraZeneca Invests $4.5 Billion to Build Advanced Manufacturing Facility in Virginia, Expanding U.S. Medicine Production
News
